Table 1. . Patients characteristics.
| Variable | Frequency (n = 73) | Percentage |
|---|---|---|
| Gender – Males – Females |
44 29 |
60% 40% |
| Median age (years) (Range) | 53 (18xx68) |
– |
| ECOG PS – PS 0 – PS 1 – PS 2 – PS 3 |
26 32 10 5 |
36% 44% 14% 6% |
| LDH level – Normal – Elevated |
31 42 |
42.5% 57.5% |
| Number of extranodal sites – 0 – 1 – 2 or more |
44 24 5 |
60% 33% 7% |
| Extranodal sites – Stomach – Bone marrow – Liver – Chest wall – Muscle – Pancreas – Paraspinal – Bone – Breast – Paratoid – Kidney – Lung – Small intestine |
9 6 5 3 2 2 2 1 1 1 1 1 1 |
- |
| Stage I Stage II Stage III Stage IV |
10 27 17 19 |
14% 37% 23% 26% |
| IPI risk score – Low – Low intermediate – High intermediate – High |
34 21 12 6 |
47% 29% 16% 8% |
| B symptoms – Absent – Present |
48 25 |
66% 34% |
| Bulky disease (≥7.5 cm) – Absent – Present |
60 13 |
82% 18% |
|
HBsAg −ve +ve HBcAB −ve +ve HBV DNA Not detectable Detectable |
72 1 73 0 1 0 |
98% 2% 100% 0% 100% 0% |
|
HCVAb −ve +ve HCV RNA Not detectable Detectable |
43 30 20 10 |
59% 41% 77% 33% |
ECOG: Eastern Cooperative Oncology Group; IPI: International Prognostic Index; PS: Performance status.